top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

uniQure Announces Dosing of First Patients in Europe Open-Label Trial of AMT-130

katie8288
Feb 7, 2022
0 min read

Recent Posts

Potential Therapies Whitepaper

Your Voices, Heard: What Our Community Told Us About HD Therapies

Skyhawk Therapeutics Announces the Expansion of its Global Pivotal trial into the United States, Canada, and the United Kingdom

Skyhawk Therapeutics Announces the Expansion of its Global Pivotal trial into the United States, Canada, and the United Kingdom

Update on Two Clinical Studies: GENERATION HD2 (tominersen) and POINT-HD (RG6496)

Update on Two Clinical Studies: GENERATION HD2 (tominersen) and POINT-HD (RG6496)

Comments

bottom of page